Tijdens de medische intake bij NOK Clinics bespreek je welk schema het beste past bij jouw situatie en voorkeur
De werkzame stof zorgt voor een betere insulineafgifte, een remming van het hongergevoel, en een vertraging van de maaglediging
In a study of 3,731 patients assigned to take either liraglutide or placebo, 63.2% of patients taking liraglutide lost at least 5% of their body weight and 33.1% of patients lost at least 10% of their body weight
Injection Sites and Rotation Approved injection sites include the abdomen (except within two inches of the navel), the front and outer thigh, and the back of the upper arm
16.8% average weight loss at 12 mg 2.0% HbA1c reduction at 12 mg Discontinuation due to side effects: 5.1% at 12 mg notably lower than the obesity-only TRIUMPH trials Dysesthesia also lower in this population The lower side-effect rate in the diabetes population is not fully explained yet
The skin effects may also run in two directions at once